Alembic gets FDA nod for generic Pristiq

Press enter to search
Close search
Open Menu

Alembic gets FDA nod for generic Pristiq

By Sandra Levy - 09/19/2018
Alembic Pharmaceuticals has received the Food and Drug Administration’s blessing for desvenlafaxine extended-release tablets in a 25-mg dosage strength.

The product, which is the generic of Wyeth Pharma’s Pristiq extended-release tablets 25 mg, is indicated for the treatment of major depressive disorder, or MDD.

Desvenlafaxine extended-release tablets 25 mg had a market value of approximately $13.3 million for the 12 months ending December 2017, according to IQVIA.

RELATED TOPICS